All research papers

Radium - from discovery to the present day – narrative review

Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.

Radiation Exposure from Patients During 177 Lu-DOTATATE Infusions

Evaluation of the safety and efficacy of 225Ac-PSMA-CY313 in metastatic castration-resistant prostate cancer: preliminary results

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy

Dosimetric impact of daily skin surface variations in kidney stereotactic ablative proton therapy.

Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival.

The Potential Role of 99m Tc-FAPI SPECT/CT in the Staging of Mucinous Appendiceal Adenocarcinoma.

Neuron irradiation of Caenorhabditis elegans by protons triggers base excision repair pathway with limited effect on behaviour

Investigating the feasibility of X-ray incident angle determination using radiophotoluminescent glass dosimeter

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances

Hybrid frame-mask fixation for Gamma Knife radiosurgery of an extracranial vagal schwannoma: illustrative case

Field- and filter-dependent tissue-maximum ratios for 6 MV photon

Optimizing immunotherapy–radiotherapy synergy in triple-negative breast cancer: mechanisms, clinical evidence, and therapeutic windows

Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy

Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial

PSMA binding of carbamate-containing peptidomimetics influenced by side chain length and stereocenter configuration in preclinical prostate cancer model.

Performance evaluation of a position-sensitive SiPM-based gamma camera for intraoperative imaging

Establishment of preliminary diagnostic reference levels for 18F-FDG PET/CT in adult lymphoma in Costa Rica.

Feasibility, Treatment Planning, and Clinical Results of VMAT-Based Total Body Irradiation for Pediatric Patients: Single-Center Experience.

The effects of stimulated thyroglobulin/ thyroid-stimulating hormone ratio and N1b status on the efficacy of the first I-131 treatment in patients with differentiated thyroid cancer.

Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [²²⁵Ac]Ac-DOTATATE therapy.

An Assessment of Time Toxicity in Patients Receiving [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Preoperative stereotactic body radiotherapy for early-stage luminal breast cancer: a systematic review and meta-analysis (PRELUMEN).

Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence.

Detection of calcium-associated nociceptive activity in neuropathic pain models using [51Mn]MnCl2 PET/MR

Biological and Health Effects of High-Dose and Repeated X-Ray Exposure: A Systematic Review

Recent advances in PSMA therapy - from beta to alpha

Progress in the application of ¹⁷⁷Lu- and ²²⁵Ac-targeted radionuclide therapy in pancreatic ductal adenocarcinoma.

Advanced dose accumulation methods: A comparative study in online adaptive radiotherapy for abdominal-pelvic lymph node oligometastases.

Memory circuit dosimetry in patients with brain metastases treated with Sparing Memory with Advanced Radiosurgery Targeting (SMART) technique.

Does the traffic light protocol capture dose deviations? A longitudinal CBCT-based dose-monitoring study in adaptive RT for LA-NSCLC.

Lesion Load Matters: Low-dose Spillage, Oar Impact, and Delivery Efficiency Across Robotic Radiosurgery, Ring-gantry, and C-arm Modalities in Multimetastatic Brain Stereotactic Radiotherapy.

Signaling pathways and targeted therapy in high‑risk refractory thyroid cancer: From bench to bedside (Review).

Occupational exposure assessment in ROLL procedures with Tc-99m: A Monte Carlo simulation approach.

68 Ga-FAPI-04 PET/CT Findings in Primary Hyperoxaluria Type 1.

Transformation of vestibular schwannomas into malignant peripheral sheath tumors: a systematic review and pooled analysis of patient characteristics and survival outcomes.

Radiosynthesis and preclinical evaluation of [¹¹C]Methyl-V-0219, a small molecule glucagon-like peptide-1 allosteric modulator for PET brain imaging.

Uncommon Concurrent Retinal and Cerebral Metastasis in High-risk Neuroblastoma: Diagnostic Utility of 68Ga-DOTATATE PET/CT Despite Negative 18F-FDG PET/CT.

Vertical miscentering increases eye lens radiation dose and degrades image quality in pediatric head CT: insights from an in-house heterogeneous phantom.

Clinical indications and implications of metastasis-directed therapy and primary-site treatment in metastatic urothelial carcinoma.

The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans.

Perspective on production of radioisotopes via nuclear fusion reactors.

Determination of institute specific CTV to PTV prostate margins using the 2020 BIR IGRT geometric uncertainty guidelines for a conventional linear accelerator.

Clinical evaluation of Chang attenuation-correction parameterization for CT-free 177Lu SPECT organ quantification: implications for safety dosimetry.

Targeting the TRA-1-60 Glycoepitope Enables Selective ImmunoPET Imaging of Ovarian Cancer

Explainable dual-task deep learning model for recurrence prediction and dose-sensitive region identification in HNC radiotherapy.

Stereotactic radiotherapy in brain metastases: SRS/FSRT paradox and preferences of radiation oncologists in Türkiye (TROD 10-010 study).

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary.

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

Tolerability of [¹⁶¹Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

Prognostic Value of [¹⁸F]FDG PET Combined with [⁶⁸Ga]Ga-PSMA PET as Pretreatment Imaging in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with [¹⁷⁷Lu]Lu-PSMA-617.

Clinical Trial Protocol for LPS-Boost: Intensified [¹⁷⁷Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.

Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [¹⁷⁷Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.

Using 18F-FDG and 68Ga-PSMA-11 PET/CT to evaluate salivary glands in Sjögren's Disease: Implications for Treatment Stratification

Prostate specific membrane antigen targeted ultrasmall manganese ferrite nanoparticles for PET/MR imaging of prostate cancer.

Thyroxine withdrawal prior to radioiodine therapy in papillary thyroid carcinoma - current scenarios.

Multiple Radioiodine-avid Skin Metastases From Thyroid Carcinoma Detected on Posttherapy 131I SPECT/CT.

SSTR Antagonist PET/CT Unveils Occult Hepatic Metastases in Rectal Neuroendocrine Tumor: Superiority Over 68Ga-DOTANOC and Clinical Upstaging.

Normal tissue complication probability models of late cardiopulmonary toxicity following deep inspiration breath hold for breast cancer adjuvant radiotherapy.